TrialCancer2018

NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab ± everolimus for metastatic melanoma.

Robert R McWilliams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.